scentech-medical

Breath Test for
Coronavirus Detection

Mapping the Coronavirus Fingerprint
Scentech Medical has already conducted two clinical trials, in which breath samples were collected from patients and healthy subjects for the identification of the metabolic volatile organic compounds (VOCs) associated with the Covid-19 virus.
Scentech Medical has already conducted two clinical trials, in which breath samples were collected from patients and healthy subjects for the identification of the metabolic volatile organic compounds (VOCs) associated with the Covid-19 virus.
The trials were successful in identifying biomarkers associated with the virus, which can be detected using the company’s breath analysis technology. Currently the company is working to commercialize the product. From preliminary examination of the results, it is apparent that the test will have a high level of accuracy in detecting coronavirus-positive patients.
The test will be able to detect patients at the asymptomatic stage, which will be accomplished by a straightforward, breath test providing on-the-spot results. It is also becoming apparent that beyond the detection of patients, the test will be able to detect antibodies and thus will be able to afford a similar solution to the serological test. Simultaneously, the company has started preparing for approval with the relevant medical authorities in multiple countries. The company initiated an additional study using the same technology to test the efficacy of the vaccine in patients. In addition to the clinical trials, the company is in the process of merging with the shell company BioMed NextGen (TASE:NXGN) in Israel.
For a better tomorrow

Breath Test Development
for Coronavirus Detection

Following two successful clinical trials, during which the company was able to map the biomarkers associated with the coronavirus in breath. The company is currently conducting a validation trial to commercialize its breath analysis system, the VOX. The device is designed for rapid detection of the coronavirus, with on-the-spot results in just a few minutes, even in early asymptomatic stages of the disease.
background